SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-21-000171
Filing Date
2021-02-12
Accepted
2021-02-12 16:46:19
Documents
2
Group Members
ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 ss192010_sc13ga.htm SC 13G/A 56986
2 JOINT FILING AGREEMENT ss192010_ex99a.htm EX-99.A 11673
  Complete submission text file 0000947871-21-000171.txt   70208
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 7000 SHORELINE COURT SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 100 SOUTH SAN FRANCISCO CA 94080 6502666000
FLUIDIGM CORP (Subject) CIK: 0001162194 (see all company filings)

IRS No.: 770513190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86635 | Film No.: 21628703
SIC: 3826 Laboratory Analytical Instruments